PharmaOmics Consultancy
- From Clinics to Global Pharma Pipelines
Clinical & PharmaOmics Consultancy
We help clinicians, hospitals, biotech, and governments harness omics data and AI to uncover biomarkers, stratify patients, predict drug response, and accelerate precision medicine.
- WHO WE WORK WITH
What We Do & Who We Support
Clinical & PharmaOmics Consultancy is the translational arm of MultiOmics Intelligence, bridging raw omics data with real-world applications in healthcare, pharma, and public health.
We provide expertise in biomarker discovery, patient stratification, drug response prediction, trial design, and large-scale omics strategy, serving a wide range of partners
We provide expertise in biomarker discovery, patient stratification, drug response prediction, trial design, and large-scale omics strategy, serving a wide range of partners
Clinicians & Hospitals
exploratory biomarker discovery, patient stratification, and molecular interpretation to support precision care.
Pharma & Biotech
AI-driven biomarker validation, drug response prediction, and translational insights to accelerate drug development and trial design.
Government & Public Health
population-scale data reanalysis, precision health strategies, and omics workforce training.
Academic Research Groups
collaborative analysis, grant proposals, and publication-ready outputs.
Core Capabilities
Biomarker Discovery & Validation
- Identify predictive, diagnostic, or prognostic molecular signatures.
- Validate biomarkers across multiple omics layers for translational confidence.
Drug Response & Mechanism of Action
- Predict sensitivity/resistance using AI models trained on GDSC/DepMap.
- Explore therapeutic mechanisms using transcriptomics and proteomics.
Clinical Trial & Cohort Support
- Stratify patients with omics-based clustering.
- Build exploratory AI models for trial recruitment and precision targeting.
- Generate publication- and regulatory-ready figures
Pharmacogenomics
- Provide variant–drug metabolism insights (e.g. CYP2D6, SLCO1B1).
- Clinician-ready handouts for educational and discussion purposes.
Organisational & Government Implementations
- Integration of omics data into national health initiatives.
- Population-scale biomarker discovery and stratification.
- Omics education and training for hospitals, research institutes, and public health bodies.
Biotech Consulting
- Our biotech consulting services provide expert guidance and support to biotech companies and organizations, helping them navigate the complex landscape of biotech innovation.
- OUR WORKFLOW
How It Works
- Deliverables
Deliverables You Receive
- Custom Branded Reports → Clear and decision-ready.
- Figures & Visualisations → Publication- and regulatory-friendly.
- Exploratory AI Models → Biomarker signatures and response predictions with interpretability.
- Consultancy Sessions → Expert guidance for your clinical, pharma, or public health project.
- Implementation Roadmaps → Tailored support for scaling omics into hospitals, pharma pipelines, or government programs.
Applications Across Disease Areas
Our consultancy is disease-agnostic and can be applied to any therapeutic domain, including:
- Oncology & Haematology
- Metabolic & Cardiovascular Disorders
- Neurodegenerative Diseases
- Infectious Diseases
- Rare & Genetic Disorders
- why us
Why Choose Clinical & PharmaOmics Consultancy?
- Omics + AI expertise → from single-cell datasets to national-scale health data.
- Translational focus → turning raw data into usable insights for clinics and pharma.
- Academic & industry-ready outputs → reports, dashboards, and publication-ready visuals.
- Safe & compliant → GDPR-compliant handling, framed as research/educational use.
- Scalable impact → solutions for individual clinicians, institutions, and governments.
